A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors
about
Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indicationsFragment Screening of Soluble Epoxide Hydrolase for Lead Generation-Structure-Based Hit Evaluation and Chemistry ExplorationFragment-based drug discovery using a multidomain, parallel MD-MM/PBSA screening protocol.Replacing sulfa drugs with novel DHPS inhibitorsNovel 9-(alkylthio)-Acenaphtho[1,2-e]-1,2,4-triazine derivatives: synthesis, cytotoxic activity and molecular docking studies on B-cell lymphoma 2 (Bcl-2).Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials.An overview of phenylcyclopropylamine derivatives: biochemical and biological significance and recent developments.Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screeningFormation of activity cliffs is accompanied by systematic increases in ligand efficiency from lowly to highly potent compounds.Fragment-based Binding Efficiency Indices in Bioactive Molecular Design: A Computational Approach to BACE-1 Inhibitors.Biotransformation of polyunsaturated fatty acids to bioactive hepoxilins and trioxilins by microbial enzymes.Ligand Efficiency Outperforms pIC50 on Both 2D MLR and 3D CoMFA Models: A Case Study on AR Antagonists.Protein-observed (19)F-NMR for fragment screening, affinity quantification and druggability assessment.
P2860
Q24616753-8CCC52CD-8EE5-4A5F-9A67-C605576F0E8AQ27703977-07B6BDCD-705C-444D-9709-660F70690B7BQ34595676-5EA121D6-5850-4AA9-ABCB-F22E4B0C92CDQ34823402-8CFD4A7A-ACC1-4A62-905B-1C5A6E83E0E6Q37567259-200A75EB-CB92-4A85-941E-CC43075915E6Q37975527-380C01E1-53A7-450D-BB1F-E0FE13F7DD54Q38034731-65580A34-ACB5-4D28-B04F-8EDED60BFD2FQ38785907-4D02A890-17FE-45E2-89D5-D2175864248DQ41821577-BBC348B7-CB47-4FB8-86C7-078410606EE1Q41889508-151CDE26-B989-490D-AB2A-40F4BFC6EB4FQ42927405-BE4FAD4C-08F4-493D-A7DD-6264C767BCE5Q49221673-6C683482-8A41-4571-BF36-4DA964F2E84CQ50879103-3DDC32CE-A4A1-4525-B4B9-646246127512Q51642295-960B90D8-7694-4F30-9F4B-887F07C8141C
P2860
A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@ast
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@en
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@nl
type
label
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@ast
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@en
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@nl
prefLabel
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@ast
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@en
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@nl
P2093
P356
P1476
A practical use of ligand effi ...... e epoxide hydrolase inhibitors
@en
P2093
Daisuke Tanaka
Naoki Chiyo
Naoto Kusunose
Nobuyuki Sawada
Takaaki Shiyama
Tamiki Nishimura
Tsutomu Mimoto
Yukio Tominaga
Yusuke Tsuda
P356
10.1021/JM101273E
P407
P577
2011-02-10T00:00:00Z